Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Topical Cannabidiol (CBD) for the Treatment of Chemotherapy-induced Peripheral Neuropathy

    Rochester, MN, Albert Lea, MN, Mankato, MN

  2. A Study to Evaluate Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

    Rochester, MN, Mankato, MN, Eau Claire, WI

  3. Colorectal Cancer and Peripheral Neuropathy Study

    Jacksonville, FL

  4. Spinal Cord Stimulation to Treat Chemotherapy-Induced Peripheral Neuropathy

    Rochester, MN

  5. A Study of Chemotherapy-induced Peripheral Neuropathy

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Stem Cells from Skin Fibroblasts in Patients with Hereditary Peripheral Neuropathy

    Rochester, MN


Mayo Clinic Footer